American Assets Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

American Assets Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-16,139	Closed	-$585K	–	153
2016 Q4	$585K	Buy	+16,139	New	+$644K	0.12%	125
2014 Q1	–	Sell	-34,200	Closed	-$1.37M	–	140
2013 Q4	$1.37M	Hold	34,200	–	–	0.51%	53
2013 Q3	$1.29M	Sell	34,200 -2,000	-6%	-$78K	0.45%	71
2013 Q2	$1.42M	Buy	+36,200	New	+$1.41M	0.52%	66

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Assets Investment Management's TEVA Position: Q1 2017 in Review

American Assets Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2017, closing a stake of 16,139 shares — an estimated $585K sold.

American Assets Investment Management first reported a position in TEVA in Q2 2013 and held it in 4 quarters. The position peaked at $1.42M in Q2 2013. 687 funds tracked by Wall St. Rank hold TEVA as of Q1 2017.

American Assets Investment Management reported no remaining Teva Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
American Assets Investment Management sold 16,139 Teva Pharmaceuticals shares in Q1 2017, an estimated $585K.
American Assets Investment Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 4 quarters.
American Assets Investment Management's Teva Pharmaceuticals position peaked at $1.42M in Q2 2013.
687 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2017.

Based on American Assets Investment Management's 13F filing for Q1 2017, filed 4 May 2017.